- Filed
- Jun 29, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · May 31, 2023 | 42.57M sh |
| Shares Diluted | FY 2023 · Mar 31, 2022 | 42.22M sh |
| Stock Repurchased | FY 2023 · Mar 31, 2022 | $0 |
| Capex | FY 2023 · Mar 31, 2022 | $466K |
| Operating Cash Flow | FY 2023 · Mar 31, 2022 | −$5.72M |
| Cash And Equivalents | FY 2023 · Mar 31, 2022 | $23.69M |
| Current Liabilities restated | FY 2023 · Mar 31, 2022 | $34.9M |
| Total Liabilities restated | FY 2023 · Mar 31, 2022 | $48.73M |
| Current Assets restated | FY 2023 · Mar 31, 2022 | $69.96M |
| Total Assets restated | FY 2023 · Mar 31, 2022 | $123.98M |
| Eps Diluted | FY 2023 · Mar 31, 2022 | −$0.16 |
| Eps Basic | FY 2023 · Mar 31, 2022 | −$0.16 |
| Rd Expense | FY 2023 · Mar 31, 2022 | $7.35M |
| Net Income | FY 2023 · Mar 31, 2022 | −$7.08M |
| Operating Income | FY 2023 · Mar 31, 2022 | −$6.69M |
| Gross Profit | FY 2023 · Mar 31, 2022 | $47.39M |
| Cost Of Revenue | FY 2023 · Mar 31, 2022 | $86.18M |
| Revenue | FY 2023 · Mar 31, 2022 | $133.57M |